Prosecution Insights
Prosecution Insights
26 pending office actions • 20 art units • 26 examiners • 0 of 26 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (12%) |
| §103 only | 4 (15%) |
| §112 only | 3 (12%) |
| Double-patenting only | 1 (4%) |
| Double-patenting + other | 4 (15%) |
| Multi-statute (no §101) | 11 (42%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GEIGER, RACHAEL L | 1 | 84.5% | +15.4% |
| PYLA, EVELYN Y | 1 | 55.7% | +47.6% |
| GOLDBERG, JEANINE ANNE | 1 | 45.9% | +40.9% |
| JOHNSON, KARA D | 1 | 69.1% | +24.6% |
| MARTIN, PAUL C | 1 | 41.8% | +21.7% |
| GABEL, GAILENE | 1 | 75.6% | +44.9% |
| HAMA, JOANNE | 1 | 25.1% | +38.8% |
| GU, QINHUA | 1 | 77.3% | +27.6% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.0% | +17.9% |
| CANDELARIA, JULIANA IRENE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17767340 | METHODS AND COMPOSITIONS FOR TREATING ATAXIA TELANGIECTASIA | MCLEOD, AFRICA MHAIRIE | 89d overdue |
| 18508057 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | JOHNSON, KARA D | 30d |
| 18703100 | SUBCUTANEOUS ABRASION TREATMENT FOR STRETCH MARKS | GEIGER, RACHAEL L | 54d |
| 18286405 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | MARTIN, PAUL C | 61d |
| 18532745 | COMPOSITIONS AND METHODS FOR MUTATIONS ASSOCIATED WITH SUDDEN UNEXPECTED DEATH IN PEDIATRICS (SUDP) | GOLDBERG, JEANINE ANNE | — |
| 18549676 | METHODS FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE | GABEL, GAILENE | — |
| 18280547 | METHODS OF PREDICTING RESPONSE TO ANTI-TNF BLOCKADE IN INFLAMMATORY BOWEL DISEASE | HAMA, JOANNE | — |
| 18279336 | STROMA-FREE NK CELL DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | GU, QINHUA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18508057 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | JOHNSON, KARA D | 30d |
| 18703100 | SUBCUTANEOUS ABRASION TREATMENT FOR STRETCH MARKS | GEIGER, RACHAEL L | 54d |
| 18286405 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | MARTIN, PAUL C | 61d |
| 18404389 | METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM BLOOD PRODUCTS | PYLA, EVELYN Y | — |
| 18532745 | COMPOSITIONS AND METHODS FOR MUTATIONS ASSOCIATED WITH SUDDEN UNEXPECTED DEATH IN PEDIATRICS (SUDP) | GOLDBERG, JEANINE ANNE | — |
| 18549676 | METHODS FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE | GABEL, GAILENE | — |
| 18280547 | METHODS OF PREDICTING RESPONSE TO ANTI-TNF BLOCKADE IN INFLAMMATORY BOWEL DISEASE | HAMA, JOANNE | — |
| 18279336 | STROMA-FREE NK CELL DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | GU, QINHUA | — |
| Art Unit | Apps |
|---|---|
| 1633 | 2 |
| 1632 | 2 |
| 1653 | 2 |
| 1647 | 2 |
| 1631 | 2 |
| 3715 | 2 |
| 3771 | 1 |
| 1682 | 1 |
| 1678 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18703100 | SUBCUTANEOUS ABRASION TREATMENT FOR STRETCH MARKS | GEIGER, RACHAEL L | 3771 | §102§103 | Final Rejection | 54d | Pending | Apr 19, 2024 |
| 18404389 | METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM BLOOD PRODUCTS | PYLA, EVELYN Y | 1633 | §112 | Final Rejection | — | Pending | Jan 04, 2024 |
| 18532745 | COMPOSITIONS AND METHODS FOR MUTATIONS ASSOCIATED WITH SUDDEN UNEXPECTED DEATH IN PEDIATRICS (SUDP) | GOLDBERG, JEANINE ANNE | 1682 | §101§102§112 | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18508057 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | JOHNSON, KARA D | 1632 | §103§112 | Non-Final OA | 30d | Pending | Nov 13, 2023 |
| 18286405 | CARDIOMYOCYTES AND COMPOSITIONS AND METHODS FOR PRODUCING THE SAME | MARTIN, PAUL C | 1653 | §102§103§112 | Non-Final OA | 61d | Pending | Oct 11, 2023 |
| 18549676 | METHODS FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE | GABEL, GAILENE | 1678 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18280547 | METHODS OF PREDICTING RESPONSE TO ANTI-TNF BLOCKADE IN INFLAMMATORY BOWEL DISEASE | HAMA, JOANNE | 1647 | §112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18279336 | STROMA-FREE NK CELL DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | GU, QINHUA | 1633 | §103§112Other | Non-Final OA | — | Pending | Aug 29, 2023 |
| 18360505 | COMPOSITIONS AND METHODS FOR TREATING CEREBROSPINAL FLUID DISORDERS | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §102§103 | Non-Final OA | — | Pending | Jul 27, 2023 |
| 18352730 | COMPOSITIONS AND METHODS FOR NEUROPROTECTION AND/OR NEUROREGENERATION | CANDELARIA, JULIANA IRENE | 1634 | §103§112 | Non-Final OA | — | Pending | Jul 14, 2023 |
| 18346720 | MATERIALS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO COCHLEAR AND VESTIBULAR CELLS | HUMPHRIES, NICHOLAS ADAM | 1631 | §112DP | Non-Final OA | — | Pending | Jul 03, 2023 |
| 18341584 | COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH AN IMPRINTING DEFECT | ANDERSON, JAMES D | 1629 | §112 | Non-Final OA | 171d overdue | Pending | Jun 26, 2023 |
| 18206830 | METHOD FOR TREATING CANCER | REGLAS, GEORGIANA C | 1651 | §103§112 | Non-Final OA | — | Pending | Jun 07, 2023 |
| 18320921 | SURGICAL REPAIR SIMULATION DEVICES | MCCLELLAN, JAMES S | 3715 | §103 | Final Rejection | 21d | Pending | May 19, 2023 |
| 18320927 | SURGICAL REPAIR SIMULATION DEVICES | HULL, JAMES B | 3715 | §103 | Final Rejection | 28d overdue | Pending | May 19, 2023 |
| 18042292 | INTUBATION SHIELD | DIETZ, NOE ROBERT | 3791 | §102§103 | Final Rejection | — | Pending | Feb 20, 2023 |
| 18019627 | COMPOSITIONS FOR ALTERING A MICROGLIAL CELL, AND METHODS OF USE THEREFORE | SIMMONS, CHRIS E | 1622 | §102§112Other | Non-Final OA | — | Pending | Feb 03, 2023 |
| 18016190 | TARGETING ZNF410 FOR FETAL HEMOGLOBIN INDUCTION IN BETAHEMOGLOBINOPATHIES | VANHORN, ABIGAIL LOUISE | 1636 | §112DP | Non-Final OA | — | Pending | Jan 13, 2023 |
| 18005286 | NOVEL ANTI-PD1 ANTIBODIES FOR INHIBITING T-CELL ACTIVITY | CHASE, CAROL ANN | 1646 | DP | Non-Final OA | — | Pending | Jan 12, 2023 |
| 18002633 | METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS | KIM, TAEYOON | 1631 | §103DP | Final Rejection | — | Pending | Dec 20, 2022 |
| 17921802 | COMPOSITIONS AND METHODS OF PROMOTING MYELINATION | TICHY, JENNIFER M.H. | 1653 | §103 | Final Rejection | — | Pending | Oct 27, 2022 |
| 17801238 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AN ALLERGY OR ANAPHYLAXIS | BUNNER, BRIDGET E | 1647 | §101§102§112 | Non-Final OA | — | Pending | Aug 19, 2022 |
| 17794747 | STROMA-FREE T CELL DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS | BEHARRY, ZANNA MARIA | 1632 | §103DP | Non-Final OA | — | Pending | Jul 22, 2022 |
| 17728927 | THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS | WILSON, MICHAEL C | 1638 | §103§112 | Final Rejection | — | Pending | Apr 25, 2022 |
| 17767340 | METHODS AND COMPOSITIONS FOR TREATING ATAXIA TELANGIECTASIA | MCLEOD, AFRICA MHAIRIE | 1635 | §102§103§112Other | Final Rejection | 89d overdue | Pending | Apr 07, 2022 |
| 16806587 | METHODS AND PROCEDURES FOR LIGAMENT REPAIR | MANNAN, MIKAIL A | 3774 | §103 | Final Rejection | — | Pending | Mar 02, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial